AUS
NZ
UK
CA
USA
IND
Healthcare
McKesson (NYSE:MCK) Shares Hold Flat Within NYSE Composite Index
December 31, 2025 04:08 AM PST| By Anmol KhazanchiDetailed look at McKesson Corporation healthcare distribution activities, operational segments, and market positioning within the NYSE Composite, emphasizing supply chain infrastructure and technology-enabled services.
Explore Thermo Fisher Scientific Within Russell 1000 Science
December 31, 2025 04:00 AM PST| By Anmol KhazanchiAn overview of Thermo Fisher Scientific activities across life sciences tools diagnostics services global operations and its context within the NYSE Composite and industry landscape.
DaVita Expands Kidney Care Services with Global Healthcare Focus
December 30, 2025 08:27 AM PST| By Anmol KhazanchiDaVita (NYSE:DVA) delivers kidney care through outpatient dialysis centers, offering in-center and home therapies, patient education, and clinical support across a global healthcare network.
Globus Medical (NYSE:GMED) Listed in NYSE Composite Healthcare Group
December 30, 2025 07:44 AM PST| By Anmol KhazanchiAn overview of Globus Medical operations, healthcare sector role, musculoskeletal device focus, governance practices, and placement within the NYSE Composite classification and medical technology landscape.
Merck & Co., Inc. (NYSE:MRK) S&P 500 ETF Scientific Infrastructure
December 30, 2025 12:00 AM PST| By Anmol KhazanchiMerck & Co. advances global healthcare through medicines, vaccines, biologics, and animal health products, appearing in broader market discussions where the s&p 500 etf includes large biopharmaceutical organizations.
Zoetis Inc. (NYSE:ZTS) s&p 500 companies Supporting Global Care
December 30, 2025 12:00 AM PST| By Anmol KhazanchiZoetis (NYSE:ZTS) delivers animal health solutions across pharmaceuticals, vaccines, diagnostics, and services, maintaining a strong global presence among s&p 500 companies focused on animal care and productivity.
Vertex Pharmaceuticals (NASDAQ:VRTX) Nasdaq index Sustains Scientific Depth
December 30, 2025 12:00 AM PST| By Anmol KhazanchiVertex Pharmaceuticals focuses on research-driven therapies for serious diseases, including cystic fibrosis, and remains visible in global biotechnology narratives connected to activity within the Nasdaq index.
Amicus Therapeutics (NASDAQ:FOLD) Nasdaq 100 Index Precision Biotech
December 30, 2025 12:00 AM PST| By Team Kalkine MediaAmicus Therapeutics (NASDAQ:FOLD) focuses on rare and orphan disease treatments through pharmacological chaperones and gene therapy, appearing in broader biotechnology discussions connected to the Nasdaq 100 index.
Tango Therapeutics (NASDAQ:TNGX) Nasdaq index Notes Liquidity Move
December 30, 2025 12:00 AM PST| By Anmol KhazanchiTango Therapeutics focuses on precision oncology through synthetic lethality research, developing targeted cancer therapies and appearing in broader biotechnology discussions connected to the nasdaq index.
Ironwood Pharma (NASDAQ:IRWD) Nasdaq composite Biotech Watch
December 30, 2025 12:00 AM PST| By Anmol KhazanchiIronwood Pharmaceuticals (NASDAQ:IRWD) maintains focus on gastrointestinal therapies while drawing market attention within broader healthcare narratives shaped by movements across the nasdaq composite.
Charles River Laboratories Expands Healthcare Research Capabilities
December 29, 2025 10:15 AM PST| By Anmol KhazanchiCharles River Laboratories International delivers healthcare research services, offering preclinical and clinical support while maintaining structured operations aligned with the S&P 500 index.
Immunovant (NASDAQ:IMVT) Nasdaq Today Immunology Innovation
December 29, 2025 08:00 AM PST| By Anmol KhazanchiImmunovant (NASDAQ:IMVT) focuses on FcRn-targeting antibody research for severe autoimmune diseases, appearing in broader biotechnology discussions shaped by themes highlighted across nasdaq today.
Becton, Dickinson and Company (NYSE:BDX) Shapes Global Healthcare
December 29, 2025 07:05 AM PST| By Anmol KhazanchiBecton, Dickinson and Company (NYSE:BDX) provides healthcare technologies, medical devices, and laboratory solutions, enhancing clinical workflows and research capabilities worldwide.
Danaher (NYSE:DHR) Stock Little Changed in Life Sciences Sector
December 29, 2025 06:02 AM PST| By Anmol KhazanchiFactual insight into Danaher Corporation activities across life sciences, diagnostics, and applied solutions, highlighting manufacturing integration, digital systems, and positioning within the Russell 1000 index.
SOPHiA GENETICS SA (NASDAQ:SOPH) Nasdaq Today Clinical AI Expansion
December 29, 2025 12:00 AM PST| By Anmol KhazanchiSOPHiA GENETICS (NASDAQ:SOPH) strengthens genomic and radiomic intelligence through cloud-native platforms and artificial intelligence, appearing in healthcare technology discussions shaped by nasdaq today.
Design Therapeutics, Inc. (NASDAQ:DSGN) Nasdaq Futures Neurology Programs
December 29, 2025 12:00 AM PST| By Anmol KhazanchiDesign Therapeutics develops small molecule treatments for inherited genetic diseases using its GeneTAC platform, appearing in broader biotechnology discussions influenced by activity associated with nasdaq futures.
Insulet Corporation (NASDAQ:PODD) Nasdaq Index Connected Care Ecosystem
December 29, 2025 12:00 AM PST| By Anmol KhazanchiInsulet Corporation develops tubeless insulin delivery systems through its Omnipod platform, supporting diabetes management and appearing in broader healthcare discussions linked to the nasdaq index.
Halozyme Therapeutics (NASDAQ:HALO) Nasdaq Composite Biopharma Platform
December 29, 2025 12:00 AM PST| By Anmol KhazanchiHalozyme Therapeutics develops drug-delivery platforms enabling subcutaneous biologic therapies, maintaining visibility in biopharmaceutical discussions connected to the nasdaq composite and innovation-focused healthcare sectors.
Incyte Corporation (NASDAQ:INCY) Nasdaq Index Fund Pathway Science
December 29, 2025 12:00 AM PST| By Anmol KhazanchiIncyte Corporation (NASDAQ:INCY) develops and commercializes novel oncology and inflammation therapies, appearing in broader healthcare and biotechnology conversations that include the Nasdaq index fund.
SOPHiA GENETICS (NASDAQ:SOPH) Within Nasdaq Futures Focus
December 29, 2025 12:00 AM PST| By Anmol KhazanchiSOPHiA GENETICS (NASDAQ:SOPH) advances cloud-native genomic analytics and AI-driven clinical workflows, appearing in broader healthcare technology discussions connected to movements in nasdaq futures.
